Skip to search formSkip to main contentSkip to account menu

SCH 58235

Known as: 58235, SCH, SCH-58235, SCH58235 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288:1723–7… 
Review
2004
Review
2004
beta-Lactams have recently been identified as potent, highly efficacious cholesterol absorption inhibitors (CAIs). The discovery… 
Review
2003
Review
2003
OBJECTIVE: To review the primary literature describing the pharmacology of ezetimibe and clinical trials investigating its use in… 
2002
Review
2002
Review
2002
Ezetimibe (Sch-58235) is a cholesterol absorption inhibitor under development by Schering-Plough (SP), in collaboration with… 
2001
2001
Ezetimibe (SCH58235) is a potent, selective, cholesterol absorption inhibitor. The objective of this study was to determine… 
1998
1998
A glucuronide of a novel cholesterol absorption inhibitor was synthesized on a 200-mg scale in one step via bovine liver…